Nvidia Invests $50 Million in Drug Discovery Firm Recursion
The association with Nvidia seems to have rekindled investors' interest in Recursion, whose shares have traded below their IPO price since late 2021.
Start your morning with the important global tech news of the day, covered by The Information team across five time zones.